#innovativemedicines — Public Fediverse posts

https://www.europesays.com/ch/132621/ Novartis US Invests in Data and AI Capabilities for 6,000 Employees #CellTherapy #digital #EmergingTechnology #FutureOfHealthcare #GeneTherapy #GlobalHealthcareCompanies #Innovation #InnovativeHealthcare #InnovativeMedicines #Novartis #NovartisOncologyPipeline #NovartisPharmaceuticals #OncologyDrugDevelopment #RareDiseasePatients #RareDiseaseTreatment #ReimagineMedicine #sandoz #SandozPharmaceuticals #WorkingAtNovartis

https://www.europesays.com/lu-fr/21862/ Novartis nomme un nouveau président national pour la Belgique et le Luxembourg #CellTherapy #GeneTherapy #GlobalHealthcareCompanies #InnovativeHealthcare #InnovativeMedicines #Luxembourg #novartis #NovartisOncologyPipeline #NovartisPharmaceuticals #OncologyDrugDevelopment #RareDiseasePatients #RareDiseaseTreatment #sandoz #SandozPharmaceuticals

https://www.europesays.com/ch/112699/ Novartis marks 30 years of breakthroughs, building on 250 years of discovery to reimagine what medicine can do next #CellTherapy #FutureOfHealthcare #GeneTherapy #GlobalHealthcareCompanies #Innovation #InnovativeHealthcare #InnovativeMedicines #Novartis #NovartisOncologyPipeline #NovartisPharmaceuticals #OncologyDrugDevelopment #RareDiseasePatients #RareDiseaseTreatment #ReimagineMedicine #sandoz #SandozPharmaceuticals #ScientificDiscoveries #WorkingAtNovartis

https://www.europesays.com/ch/107808/ Novartis marks 30 years of breakthroughs, building on 250 years of discovery to reimagine what medicine can do next #CellTherapy #FutureOfHealthcare #GeneTherapy #GlobalHealthcareCompanies #Innovation #InnovativeHealthcare #InnovativeMedicines #Novartis #NovartisOncologyPipeline #NovartisPharmaceuticals #OncologyDrugDevelopment #RareDiseasePatients #RareDiseaseTreatment #ReimagineMedicine #sandoz #SandozPharmaceuticals #ScientificDiscoveries #WorkingAtNovartis

https://www.europesays.com/ch/103803/ The Future of Autoimmune Disease: A Q&A You Need to Read #CellAndGeneTherapy #CellTherapy #FutureOfHealthcare #GeneTherapy #GlobalHealthcareCompanies #Immunology #Innovation #InnovativeHealthcare #InnovativeMedicines #MedicalInnovations #Novartis #NovartisOncologyPipeline #NovartisPharmaceuticals #OncologyDrugDevelopment #PatientEducation #PatientVoices #RareDiseasePatients #RareDiseaseTreatment #ReimagineMedicine #sandoz #SandozPharmaceuticals #ScientificResearch

https://www.europesays.com/ch/98973/ A Conversation Women Wish They’d Had: Understanding the Risk of Breast Cancer Coming Back #cancer #CellTherapy #DataScience #FutureOfHealthcare #GeneTherapy #GlobalHealthcareCompanies #InnovativeHealthcare #InnovativeMedicines #LivingWithDisease #Novartis #NovartisOncologyPipeline #NovartisPharmaceuticals #OncologyDrugDevelopment #PatientVoices #RareDiseasePatients #RareDiseaseTreatment #ReimagineMedicine #sandoz #SandozPharmaceuticals

https://www.europesays.com/ch/98667/ President of the Republic of Slovenia Nataša Pirc Musar visits Novartis in Basel #InnovativeMedicines #Novartis #NovartisSlovenia #PharmaceuticalIndustry #President

https://www.europesays.com/ch/86564/ Novartis in Albania | Novartis Albania #GeneTherapy #HealthcareInnovation #InnovativeMedicines #MedicalEducationellTherapy #Novartis #NovartisAlbania #PatientAccess #ResearchAndDevelopment

https://www.europesays.com/ch/81787/ India needs to remain attractive for innovation-led investment: Judith Love, Novartis #ClinicalTrials #India #IndianPharmaceuticalMarket #InnovativeMedicines #JudithLove #Novartis #NovartisIndia #RadioligandTherapy

https://www.europesays.com/ch/65806/ Stroke Awareness Month: What You Should Know About Your Stroke Risk #AtrialFibrillation #CardiovascularDisease #CellTherapy #DiseaseAwareness #GeneTherapy #GeneticDisease #GlobalHealthcareCompanies #HeartDisease #InnovativeHealthcare #InnovativeMedicines #Novartis #NovartisOncologyPipeline #NovartisPharmaceuticals #OncologyDrugDevelopment #RareDiseasePatients #RareDiseaseTreatment #sandoz #SandozPharmaceuticals #stroke #StrokeAwarenessMonth #StrokeRisk

https://www.europesays.com/ch/65358/ How This Former Army Officer Helps Deliver Cancer Treatments to Patients, Through Hurricanes and Beyond #Careers #CellTherapy #EmergingTechnology #GeneTherapy #GlobalHealthcareCompanies #InnovativeHealthcare #InnovativeMedicines #Novartis #NovartisOncologyPipeline #NovartisPharmaceuticals #Oncology #OncologyDrugDevelopment #RareDiseasePatients #RareDiseaseTreatment #sandoz #SandozPharmaceuticals #TargetedTherapy #WorkingAtNovartis

https://www.europesays.com/ch/63078/ Novartis seeks to deepen India innovation play #ClinicalResearch #InnovativeMedicines #Novartis #NovartisIndia #PhaseITrials #SwissPharma

https://www.europesays.com/ch/49826/ Supercharged Ireland | Business Powered By AI #CellTherapy #GeneTherapy #GlobalHealthcareCompanies #InnovativeHealthcare #InnovativeMedicines #Novartis #NovartisOncologyPipeline #NovartisPharmaceuticals #OncologyDrugDevelopment #RareDiseasePatients #RareDiseaseTreatment #sandoz #SandozPharmaceuticals

https://www.europesays.com/ch/48248/ New long term social impact and sustainability targets #CellTherapy #GeneTherapy #GlobalHealthcareCompanies #InnovativeHealthcare #InnovativeMedicines #Novartis #NovartisOncologyPipeline #NovartisPharmaceuticals #OncologyDrugDevelopment #RareDiseasePatients #RareDiseaseTreatment #sandoz #SandozPharmaceuticals

https://www.europesays.com/ch/41164/ Changing Lives: Inside the Novartis Corporate Teen Mentoring Program #Careers #CellTherapy #digital #GeneTherapy #GlobalHealthcareCompanies #Innovation #InnovativeHealthcare #InnovativeMedicines #Novartis #NovartisOncologyPipeline #NovartisPharmaceuticals #OncologyDrugDevelopment #RareDiseasePatients #RareDiseaseTreatment #ReimagineMedicine #sandoz #SandozPharmaceuticals #WorkingAtNovartis

https://www.europesays.com/uk/757039/ Impact of US Drug Price Regulations on Germany’s Pharma Market #DrugPricingStrategies #EU #Europe #GermanPharmaLobby #Germany #HealthSystemResponse #InnovativeMedicines #MarketImpact #MedicineLaunches #PharmaDeutschland #PricingChallenges

Dutch struggling to provide patients with quick, affordable access to innovative medicines https://www.euractiv.com/section/health-consumers/news/dutch-struggling-to-provide-patients-with-quick-affordable-access-to-innovative-medicines/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #cancer #InnovativeMedicines #TheNetherlands

Dutch drugs association wants clear, predictable reimbursement procedures from pharma package [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/dutch-drugs-association-wants-clear-predictable-reimbursement-procedures-from-pharma-package/?utm_source=dlvr.it&utm_medium=mastodon #EUPharmaPackage #innovativemedicines #TheNetherlands